The National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network Beneficial Effects of Antenatal Repeated Steroids study: impact of repeated doses of antenatal corticosteroids on placental growth and histologic findings

Objective In utero exposure to repeated doses of antenatal corticosteroids (ACSs) has been shown to reduce fetal growth. Our goal was to evaluate whether weekly betamethasone (R-ACS) alters placental growth and histologic findings. Study Design In a multicenter randomized controlled trial of R-ACS v...

Full description

Saved in:
Bibliographic Details
Published in:American journal of obstetrics and gynecology 2007-09, Vol.197 (3), p.281.e1-281.e8
Main Authors: Sawady, Joram, MD, Mercer, Brian M., MD, Wapner, Ronald J., MD, Zhao, Yuan, MSc, Sorokin, Yoram, MD, Johnson, Francee, RN, BSN, Dudley, Donald J., MD, Spong, Catherine Y., MD, Peaceman, Alan M., MD, Leveno, Kenneth J., MD, Harper, Margaret, MD, MS, Caritis, Steve N., MD, Miodovnik, Menachem, MD, Thorp, John M., MD, Ramin, Susan, MD, Carpenter, Marshall W., MD, Rouse, Dwight J., MD
Format: Article
Language:English
Subjects:
Adult
antenatal corticosteroid
Betamethasone - pharmacology
Biological and medical sciences
Bones, joints and connective tissue. Antiinflammatory agents
Dose-Response Relationship, Drug
Double-Blind Method
Female
Gestational Age
Glucocorticoids - pharmacology
Gynecology. Andrology. Obstetrics
histopathologic finding
Humans
Medical sciences
Obstetrics and Gynecology
Pharmacology. Drug treatments
placenta
Placenta - abnormalities
Placenta - drug effects
Placenta - pathology
Placentation
Pregnancy
Prenatal Injuries - chemically induced
preterm birth
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective In utero exposure to repeated doses of antenatal corticosteroids (ACSs) has been shown to reduce fetal growth. Our goal was to evaluate whether weekly betamethasone (R-ACS) alters placental growth and histologic findings. Study Design In a multicenter randomized controlled trial of R-ACS vs a single course of ACS followed by weekly placebo (S-ACS), placentas were weighed after removal of the membranes and umbilical cord. A single pathologist who was masked to study group and pregnancy outcomes performed histologic evaluation for placental calcifications, infarction, fibrin deposition, and hemorrhage or thrombus formation, acute and chronic chorioamnionitis, fibromuscular vascular hyperplasia, nucleated red blood cells, and villous crowding, edema, fibrosis, or fibrinoid necrosis. Findings were compared between study groups and according to the number of courses of ACS. Results One hundred ninety-four placentas were available for evaluation. Univariable analyses revealed no differences between study groups in any of the 19 evaluated histologic parameters between R-ACS and S-ACS groups overall or in analyses that were restricted to deliveries at
ISSN:0002-9378
1097-6868
DOI:10.1016/j.ajog.2007.06.041